Company
Decoy Therapeutics Inc. (DCOY)
Standardized SEC financial data for Decoy Therapeutics Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001615219 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-100.0%
Return on equity
-212.6%
Free cash flow
-$5.4M
Current ratio
2.13×
EPS (diluted)
$-129.10
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $5.2M | $1.8M | $0 | — | — | — |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.1M | $29.2M | $12.1M | $5.9M | $2.4M | $10.7M |
| Accounts receivable |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$10.3M | -$10.2M | -$17.6M | -$12.8M | -$4.5M | -$4.8M |
| Capital expenditures |
Get DCOY data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/DCOY/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/DCOY/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"